Steven Brem, MD

Richardson TE, Samanamud J, Virata MC, Mir E, Kandoi S, Slocum CC, Shi DD, Savani MR, Yokoda RT, Sharma S, Yong RL, Bederson JB, Silva-Hurtado TJ, Nguyen P, Hiya S, Maldonado- Díaz, Clare K, Vij M, Nishikawa Y, Umphlett M, Hatanpaa KJ, Brem S, Viapiano MS, Snuderl M, Hambardzumyan D, Walker JM, Abdullah KG, McBrayer SK, Tsankova NM. Validation of proposed cIMPACT‑NOW update 12 molecular grading criteria for IDH‑mutant astrocytoma. , Acta Neuropathologica, 152: 2026,9

Virata MC, Samanamud J, Slocum CC, Kandoi S, Nguyen P, Savani MR, Shi DD, Sharma S, Hiya S, Maldonado-Díaz C, Clare K, Yokoda RT, Vij M, Mir E, Nishikawa Y, Umphlett, Yong RL, Bederson JB, Silva-Hurtado TJ, Brem S, Hambardzumyan D, Snuderl, Viapiano MS, Abdullah KG, McBrayer SK, Hatanpaa, Walker JM, Tsankova NM, Richardson TE. Expanding the molecular grading criteria in IDH-mutant astrocytoma. , NeuroOncology, Mar 28:: 2026,noag069

Li EJ, Kraya A, Costa-Pinheiro P, Scheuermann J, Young AJ, Schubert E, Aboian M, Doot R, Ware JB, Pantel A, Storm PB, Resnick AC, Amankulor NM, O’Rourke DM, Desai A, Nasrallah MP, Brem S, Bagley SJ, Mankoff D, Nabavizadeh A Metabolic imaging and molecular signatures reveal metabolic phenotypes in recurrent glioblastoma. , J Nucl Med, 67(6): 2026,849-856

Almasri S, Gandi OH, Wei KL, Rashad MS, Edavettal MJ, Yu N, Ahmed W, Tierradentro-Garcia LO, Feroze A, Brem S, Bagley L, Choudhri O Management strategies and clinical outcomes for thalamic neuroepithelial cysts: 10-year single center experience. , J Clin Neurosci: 2026

Cordell EC, Mansour M, Pantel AR, Schubert E, Nabavizadeh A, Mohan S, Maloney E, Prior T, Angeloni N, Blessing C, Frangos S, Coghlan L, Wileyto EP, O’Rourke DM, Brem S, Desai AS, Bagley SJ. A phase 2 study of niraparib concomitant with tumor treating fields in patients with recurrent grade 4 glioma , Neurooncol Advances, 8(1): 2026

Gujral J, Gandhi OH, Amanullah AA, Singh SB, Ayubcha C, Patil S, Werner TJ, Revheim M-E, Brem S, Alavi A Somatostatin receptor PET in meningioma: diagnosis, therapy, and surveillance , Nucl Med Commun. , 47(5): 2026

181., Wei S, Deng Y, Lee J, Lan H, Yang Z, Labrie M, Betts CB, Duan H, Tate B, Pucilowska J, Frederick D, Lawless AR, Sharova T, Yang Y, Hu W, Beasley GM, Schuchter LM, Wang X, Xu W, Yong G, Vandenberg MEG, Torigian DA, Sivagnanam, Du K, Sugarman E, McGettigan S, Zhen C, Al-Rohil RN, Selim MA, Datto MB, Lopez G, Nair SK, Ashley DM, Xu X, Amaravadi RK, Karakousis GC, O’Rourke DM, Brem S, O’Malley BW, Demirkan G, Yu S, Lu Y, Camp T, Patterson JA, Wei Z, Corless C, Gabrilovich DI, Mou Y, Flaherty KT, Coussens LM, Boland G, Herlyn M, Mills G, Liu L, Zhang G. A longitudinal, multi-omic atlas reveals the emergence of a spatially organized immunosuppressive ecosystem in resistant melanoma. , Cell Rep Med. , 7(4): 2026,102716

Friedes C, Berger M, Linkowski L, Hollawell C, Hubbeling H, Alexander D, Kurtz G, Lustig RA, Dorsey JF, Desai AS, Phillips RE, Brem S, Davatzikos, Nasrallah M, O’Rourke DM, Jackson C, Amankulor NM, Alonso-Basanta, Mohan S, Bagley SJ, Lebow ES Clinical, molecular, and immunologic determinants of survival in WHO-defined IDH-wildtype glioblastoma treated with radiotherapy: a large real-world cohort study. , J Neurooncol, 177(3): 2026

Akbari H, Mohan S, Liu F, Jiang C, Kazerooni AF, Berger M, Rathore S, Bilello M, Sako C, Garcia J, Brem S, Bakas S, Mamourian E, Pepin A, James P, Dorsey J, Singh A, Parker D, Verma R, Cao Q, Bagley SJ, Desai A, O’Rourke DM, Shinohara RT, Nasrallah MP, Teo BK, Kurtz G, Shukla G, Alonso-Basanta M, Lustig RA, Davatzikos C. Personalized machine learning-guided radiation dose escalation in newly diagnosed glioblastoma: A prospective clinical trial with matched controls. , Nature Communications, 17(1): 2026,6413

Kotecha R, Chiang V, Tom MC, Parent EE, Nabavizadeh A, Siegel BA, Huang J, Zan E, Peddi S, Brem S, Ware M, Sulman EP, Kesari S, Pope WB, Holmes R, Chau A, Teoh EJ, Chao ST, Aboian M, and the PURSUE Study Group 18F-fluciclovine-PET for detection of recurrent brain metastases after radiation therapy: Image interpretation criteria and diagnostic performance from the PURSUE study. , Int J Radiat Oncol Biol Phys, 125(5): 2026